EWTX
Edgewise Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Edgewise Therapeutics, Inc.
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US